This conference consolidates IDIBELL’s internal collaboration, promoting the exchange of knowledge and connecting more than 125 professionals.
The first edition of the EPIBELL Programme Research Conference takes place Read More »
More than 100 pneumococcal serotypes are known, and invasive pneumococcal disease (IPD) caused by serotype 3 is linked to a high mortality rate.
Yesterday was the award ceremony of the fourth edition of the hna Foundation’s Scientific Health Research Awards, which this year has focused on Amyotrophic Lateral Sclerosis (ALS), a neurodegenerative disease with no cure and few diagnostic tools.
This recognition, which must be renewed every five years, allows the Institute to access various sources of funding offered by the Ministry of Health.
This is the VIII edition of the Barcelona Firefighters Solidarity Nautical Mile, which will be held on Sunday, June 30 on Bogatell beach (Barcelona).
Virginia Nunes, pioneer of human genetics and coordinator of the Genes, Disease and Therapy Program at the Bellvitge Biomedical Research Institute (IDIBELL), passed away on May 24, 2024, after a long disease.
The dinner features the collaboration of renowned chefs, and will also include live musical accompaniment and other activities.
The Pinnae Foundation organizes a charity dinner to support ALS research Read More »
The predoctoral researcher from IDIBELL and the Bellvitge Hospital Andrea Urbina receives the award in the Research category.
A European study led at a national level by neurosurgeons from the Bellvitge University Hospital and IDIBELL has provided relevant new knowledge on the impact of surgery on the prognosis and recovery of patients with severe haemorrhagic stroke.
Researchers from IDIBELL, UB and the LMU of Munich discover a viral strain capable of inducing immunogenic cell death in tumor cells. The virus described is effective in the treatment of tumors such as melanoma, colon or renal cancer.
New advance in viral cancer immunotherapy Read More »
